13045_2019_827_MOESM6_ESM.docx (2.58 MB)
MOESM6 of Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma
journal contribution
posted on 2019-12-06, 04:44 authored by Liwei Lang, Chloe Shay, Xiangdong Zhao, Yuanping Xiong, Xuli Wang, Yong TengAdditional file 6: Figure S6. The levels of phospho-Src and Ki67 in HN8-derived orthotopic xenograft tumors receiving different treatments determined by IHC. The representative IHC images were shown in (A) and quantification of IHC staining using Image pro-Plus6.0 was shown in (B). *p<0.05; **p<0.01.